Azienda Socio Sanitaria Territoriale Brianza (ASST Brianza)
- Address
- Via Mazzini, 1, 20832 Desio (MB), Italy
Azienda Socio Sanitaria Territoriale Brianza (ASST Brianza)
ASST Brianza is actively engaged in advancing renal medicine through participation in clinical research focused on innovative therapeutic approaches for kidney disease management. The center demonstrates particular expertise in investigating novel treatments aimed at slowing the progression of chronic kidney conditions in diverse patient populations.
- Non-diabetic chronic kidney disease management and treatment
- Evaluation of mineralocorticoid receptor antagonists in renal protection
- Clinical assessment of disease progression biomarkers in kidney disease
The research center is committed to evaluating finerenone and other emerging therapeutic agents as part of comprehensive Standard of Care protocols, with the goal of demonstrating superior outcomes in delaying kidney disease progression. Through rigorous clinical trial participation, ASST Brianza contributes to the evidence base supporting improved long-term renal outcomes for patients with chronic kidney disease.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 566 other sites in Italy
Therapeutic Area Benchmark — Italy
Select a therapeutic area to compare against other sites in Italy.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Italy
Market Share
Country: Italy
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Azienda Socio Sanitaria Territoriale Brianza (ASST Brianza)
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety of Finerenone in Non-Diabetic Chronic Kidney Disease: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study | Bayer AG | Phase III | Not Recruiting | Oct 2021 | Feb 2026 |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Finerenone | 1 | Unknown | 2021-10-18 | 2021-10-18 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.